Xencor reported $-22832000 in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Alnylam Pharmaceuticals USD 4.89M 13.19M Jun/2025
Amgen USD 2.26B 1.34B Jun/2025
Arrowhead Research USD -165550000 546.75M Jun/2025
AstraZeneca USD 3.51B 1.3B Jun/2025
Biogen USD 816.6M 233.8M Jun/2025
Bristol-Myers Squibb USD 2.26B 1.92B Jun/2025
Cytokinetics USD -111506000 44.12M Jun/2025
GlaxoSmithKline GBP 2.07B 462M Jun/2025
J&J USD 6.94B 443M Jun/2025
MacroGenics USD -35344000 17.49M Jun/2025
Merck USD 6.36B 149M Jun/2025
Novartis USD -9190000000 13.87B Jun/2025
Pfizer USD 2.6B 3.33B Jun/2025
Regeneron Pharmaceuticals USD 1.52B 608.6M Jun/2025
Roche Holding CHF 11.29B 2.68B Jun/2024
Xencor USD -22832000 16.77M Jun/2025